Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 11, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • SARS-CoV-2
  • Page 12

Tag: SARS-CoV-2

  • BiotechToday
  • World

New model analyzing viral mechanisms- a potential new chapter in viral disease treatment

bioxone October 11, 2020October 10, 2020

-Sampriti Roy, Asutosh College, University of Calcutta. “As a result of this unique human viral expression system based on stem cells, it will now be possible to simulate a large number of diseases in their progression and, for the first time, analyse them with the utmost precision”, said Guiscard Seebohm, delighted at the success of […]

Read More
  • BiotechToday
  • World

Convalescent Plasma Therapy – Promising need of the Hour!

bioxone October 10, 2020October 10, 2020

-Raddur Samaddar, Team bioXone While the world is waiting for a COVID-19 vaccine with absolute eagerness, the closest promising immunological treatment that can help stop the rate of the ever-increasing spread of the SARS-CoV-2 virus is the Convalescent Plasma Therapy. This treatment relies upon the transfusion of the anti-viral antibodies from donors to recipients with […]

Read More
  • BiotechToday
  • India
  • World

Can mutation make you lose your sense of smell?

bioxone October 10, 2020October 10, 2020 10

-Husna, Amity University Kolkata The loss in sense of smell and taste experienced most commonly due to viral fever is termed as Anosmia. Millions of olfactory receptor cells are present in our nasal cavity. These cells captures molecules with specific odour and activate a nerve response which then carries the signal to the brain where […]

Read More
  • BiotechToday
  • World

COVID-19: Will Social Distancing help?

bioxone October 9, 2020October 8, 2020

Sashreek Ganguly, Amity University Kolkata There is enormous evidence that inhalation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) acts as a major transmission route for coronavirus disease 2019 (COVID-19). It is quintessential to discuss the various routes of viral transmission and ensure efficiency and consistency in guidelines provided to the public. To do this, […]

Read More
  • BiotechToday
  • World

Complement Tissue injury and its protection during COVID-19

bioxone October 7, 2020October 7, 2020 2

Srilagna Sarkar, Amity University Kolkata Even though the novel coronavirus disease originates in the lungs, it may extend to other tissues and cause organ damage including cardiac injury, multiorgan failure, and even acute kidney injury, associating it with an increased risk of death. Although the COVID-19 tissue injury is not primarily mediated by any viral […]

Read More
  • BiotechToday
  • World

Large-Scale Screening based new natural compounds show anti-viral effects on SARS-CoV-2

bioxone October 6, 2020October 5, 2020

Snigdha Ghosh, Amity University Kolkata COVID-19 pandemic has spread tremors around the globe within a few months and this December 2020, it’s going to be one year that we all are combating to formulate and identify such effective drugs against it. Research and multiple clinical trials proved that some anti-viral drugs like – (Remdesivir, Chloroquine) […]

Read More
  • BiotechToday
  • World

Monoclonal antibodies against SARS-CoV-2 spike protein

bioxone October 6, 2020October 6, 2020

Prama Ghosh, Amity University Kolkata The alarming hypothesis that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic to be around for several years calls for rapid and successful therapies. Though anti-SARS-CoV-2 spike monoclonal antibodies originated from mice have shown robust performance in various immunoassays including western blotting, ELISA, immunofluorescence, and immunoprecipitation, there is still a […]

Read More
  • BiotechToday
  • World

Long-term immunity against Coronavirus is a myth

bioxone October 5, 2020October 5, 2020

Devyani Goswami, Amity University Kolkata It is about a year now that the SARS-CoV-2 has disturbed and changed the daily lifestyle of people all over the world. A vaccine against this virus is what we are hoping for, but that too comes with a drawback that it won’t be able to provide a long-term immunity […]

Read More
  • BiotechToday
  • World

You could be at greater COVID risk if you have Neanderthal genes

bioxone October 5, 2020October 5, 2020 3

-Anuska Sen, Team bioXone Neanderthals also called Homo neanderthalensis or Homo sapiens neanderthalensis are an extinct group of early humans, which was existent almost 40,000 years back. These individuals lived in Eurasia until they became extinct and there are pieces of evidence that till date a certain percentage of Europeans and South Asians are genetically linked to these Neanderthals. […]

Read More
  • BiotechToday
  • India
  • World

Here’s how COVID-19 vaccine BNT162b1 produces human antibody and helper T-cell responses

bioxone October 4, 2020October 4, 2020

Ayooshi Mitra, Amity University Kolkata To avert the spread of the pandemic of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), a successful vaccine is needed. In an examination directed recently, safety, tolerability, and neutralizer reaction information from an on-going placebo-controlled treatment observer-blinded phase 1/2 coronavirus disease 2019 (COVID-19) vaccine trial BNT162b1, a lipid nanoparticle (LNP) nucleoside-modified […]

Read More

Posts navigation

1 … 8 9 10 11 12 13

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy